Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors
Epstein-Barr virus (EBV) is closely associated with several lymphomas (endemic Burkitt lymphoma, Hodgkin lymphoma and nasal NK/T-cell lymphoma) and epithelial cancers (nasopharyngeal carcinoma and gastric carcinoma). To maintain its persistence in the host cells, the virus manipulates the ubiquitin-...
Main Authors: | Kwai Fung Hui, Kam Pui Tam, Alan Kwok Shing Chiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/9/11/352 |
Similar Items
-
بررسی بیان آنتیژن هستهای Epstein-Barr Virus در گروهی از بیماران مبتلا به کارسینوم پاپیلاری تیروئید در شهر اصفهان
by: Mozhgan Mokhtari, et al.
Published: (2017-03-01) -
Novel patterns of the Epstein-Barr nuclear antigen (EBNA-1) V-Val subtype in EBV-associated nasopharyngeal carcinoma from Vietnam
by: Thuan LD, et al.
Published: (2019-08-01) -
Epstein–Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle
by: Pok Man Hau, et al.
Published: (2017-11-01) -
Potential Cellular Functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus
by: Danielle Westhoff Smith, et al.
Published: (2013-01-01) -
NF-κB Signaling Regulates Epstein–Barr Virus BamHI-Q-Driven EBNA1 Expression
by: Rob J. A. Verhoeven, et al.
Published: (2018-04-01)